SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-24-000045
Filing Date
2024-06-14
Accepted
2024-06-14 16:04:58
Documents
19
Period of Report
2024-06-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20240614.htm   iXBRL 8-K 35395
2 EX-3.1 slrx-certificateofamendm.htm EX-3.1 5418
3 EX-99.1 a061224slrxreversesplit-fi.htm EX-99.1 13138
7 image_0a.jpg GRAPHIC 76891
8 slrx-certificateofamendm001.jpg GRAPHIC 274171
9 slrx-certificateofamendm002.jpg GRAPHIC 53324
10 slrx-certificateofamendm003.jpg GRAPHIC 50364
  Complete submission text file 0001615219-24-000045.txt   816394

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240614.xsd EX-101.SCH 1926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240614_lab.xml EX-101.LAB 22592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240614_pre.xml EX-101.PRE 13078
22 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240614_htm.xml XML 2824
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 241044665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)